Update README.md
Browse files
README.md
CHANGED
|
@@ -1,5 +1,9 @@
|
|
| 1 |
---
|
| 2 |
license: mit
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3 |
---
|
| 4 |
|
| 5 |
|
|
@@ -7,14 +11,14 @@ license: mit
|
|
| 7 |
|
| 8 |
This repo contains the datasets used in the [ASAP-Polaris-OpenADMET challenge](https://polarishub.io/blog/antiviral-competition), comprising Potency, ADMET and crystallography data from [ASAP Discovery's](https://asapdiscovery.org/) SARS-CoV-2 / MERS-CoV main protease inhibitor program.
|
| 9 |
|
|
|
|
| 10 |
|
| 11 |
## Experimental data collection
|
| 12 |
|
| 13 |
-
The crystallography experiments for the challenge were performed by the University of Oxford and Diamond Light Source. See dx.doi.org/10.17504/protocols.io.ewov194x7lr2/v1 and
|
| 14 |
|
| 15 |
|
| 16 |
-
In-vitro inhibition assays (potency) for
|
| 17 |
|
| 18 |
|
| 19 |
-
ADMET assays for this sub-challenge were performed by Bienta with protocols for microsomal stability:
|
| 20 |
-
|
|
|
|
| 1 |
---
|
| 2 |
license: mit
|
| 3 |
+
tags:
|
| 4 |
+
- chemistry
|
| 5 |
+
- biology
|
| 6 |
+
- drug-discovery
|
| 7 |
---
|
| 8 |
|
| 9 |
|
|
|
|
| 11 |
|
| 12 |
This repo contains the datasets used in the [ASAP-Polaris-OpenADMET challenge](https://polarishub.io/blog/antiviral-competition), comprising Potency, ADMET and crystallography data from [ASAP Discovery's](https://asapdiscovery.org/) SARS-CoV-2 / MERS-CoV main protease inhibitor program.
|
| 13 |
|
| 14 |
+
More detail on the competition and its design can be found at the [relevant preprint](https://chemrxiv.org/engage/chemrxiv/article-details/695db4c1900d745c43b8ec3e)
|
| 15 |
|
| 16 |
## Experimental data collection
|
| 17 |
|
| 18 |
+
The crystallography experiments for the challenge were performed by the University of Oxford and Diamond Light Source. See [here](https://dx.doi.org/10.17504/protocols.io.ewov194x7lr2/v1) and [here](dx.doi.org/10.17504/protocols.io.kqdg326y7v25/v1) for the crystallography conditions for MERS-CoV and SARS-CoV-2 respectively.
|
| 19 |
|
| 20 |
|
| 21 |
+
In-vitro inhibition assays (potency) for the challenge were performed by the Weizmann Institute of Science. See [here](https://dx.doi.org/10.17504/protocols.io.8epv5rzm4g1b/v1) and [here](dx.doi.org/10.17504/protocols.io.81wgbye9nvpk/v4) for the experimental conditions for MERS-CoV and SARS-CoV-2 respectively.
|
| 22 |
|
| 23 |
|
| 24 |
+
ADMET assays for this sub-challenge were performed by Bienta with protocols for [microsomal stability](https://dx.doi.org/10.17504/protocols.io.5qpvokdb9l4o/v1), [Kinetic Solubility (KSOL)](https://dx.doi.org/10.17504/protocols.io.j8nlk8y41l5r/v1), [Permeability](https://dx.doi.org/10.17504/protocols.io.n2bvjne6ngk5/v1) and [LogD](https://dx.doi.org/10.17504/protocols.io.e6nvw14kdlmk/v1) at each respective link
|
|
|